Analysis of the duration of combination therapy that is necessary for hepatitis C (HCV) genotype 1 eradication

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN56141572

Enrollment

Registered

2004-09-30

Start date

2003-10-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infections and Infestations: Hepatitis C Infections and Infestations Chronic viral hepatitis

Interventions

Randomised Controlled Trial 1. Chemotherapy 1 2. Chemotherapy 2

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 50 patients from Hepatology

Exclusion criteria

Exclusion criteria: Does not match inclusion criteria

Design outcomes

Primary

Measure	Time frame
Viral clearance	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026